X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS

期刊標題檢索 J OCUL PHARMACO 最新評論: How long does it take to accept submissions? (2023-11-29)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS]您好,您是該頁面的第 14345 位訪客。

期刊簡介
期刊名稱JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
LetPub Score
5.2
50 ratings
Rate

Reputation
6.4

Influence
3.9

Speed
7.1

期刊簡稱J OCUL PHARMACOL TH
ISSN1080-7683
E-ISSN1557-7732
h-index53
CiteScore
CiteScoreSJRSNIPCiteScore Rank
4.600.5990.802
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Ophthalmology
Q131 / 137
Category: Medicine
Subcategory: Pharmacology (medical)
Q2109 / 272
Category: Medicine
Subcategory: Pharmacology
Q3163 / 313

自引率 (2023-2024)5.30%自引率趨勢
掲載範囲
Journal of Ocular Pharmacology and Therapeutics is the only peer-reviewed journal that combines the fields of ophthalmology and pharmacology to enable optimal treatment and prevention of ocular diseases and disorders. The Journal delivers the latest discoveries in the pharmacokinetics and pharmacodynamics of therapeutics for the treatment of ophthalmic disorders.

Journal of Ocular Pharmacology and Therapeutics coverage includes:

Glaucoma
Cataracts
Retinal degeneration
Ocular infection, trauma, and toxicology
Ocular drug delivery and biotransformation
Ocular pharmacotherapy/clinical trials
Ocular inflammatory and immune disorders
Gene and cell-based therapies
Ocular metabolic disorders
Ocular ischemia and blood flow
Proliferative disorders of the eye
Eyes on Drug Discovery - written by Gary D. Novack, PhD, featuring the latest updates on drug and device pipeline developments as well as policy/regulatory changes by the FDA.
官方網站http://www.liebertpub.com/overview/journal-of-ocular-pharmacology-and-therapeutics/40/
在線稿件提交http://www.liebertpub.com/overview/journal-of-ocular-pharmacology-and-therapeutics/40/
開放訪問No
出版商Mary Ann Liebert Inc.
主題領域医学
出版國/地區UNITED STATES
發行頻率四半期刊行
創刊年1995
每年文章數69每年文章數趨勢
黃金OA百分比15.05%
Web of Science 四分位
2023-2024
WOS Quartile: Q2

CategoryEditionJIF QuartileJIF RankingJIF Percentage
OPHTHALMOLOGYSCIEQ244/95
PHARMACOLOGY & PHARMACYSCIEQ3231/354
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1080-7683%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Average 1 Month(s)
競爭力 *來自作者的數據: About 5%
參考鏈接
相關期刊 【JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    PROGRESS IN RETINAL AND EYE RESEARCHH-index: 131

    CiteScore: 34.10
    OPHTHALMOLOGYH-index: 217

    CiteScore: 22.30
    Ocular SurfaceH-index: 53

    CiteScore: 11.60
    SURVEY OF OPHTHALMOLOGYH-index: 120

    CiteScore: 10.30
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCEH-index: 196

    CiteScore: 6.90
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGYH-index: 67

    CiteScore: 7.60
    AMERICAN JOURNAL OF OPHTHALMOLOGYH-index: 171

    CiteScore: 9.20
    BRITISH JOURNAL OF OPHTHALMOLOGYH-index: 137

    CiteScore: 10.30
    CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIEH-index: 44

    CiteScore: 3.20
    ACTA OPHTHALMOLOGICAH-index: 77

    CiteScore: 7.60
    學科內最受檢索的期刊 頁面查看次數
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE67594
    OPHTHALMOLOGY43535
    EXPERIMENTAL EYE RESEARCH43325
    BRITISH JOURNAL OF OPHTHALMOLOGY40911
    EYE40899
    CURRENT EYE RESEARCH38485
    CORNEA37600
    ACTA OPHTHALMOLOGICA36977
    AMERICAN JOURNAL OF OPHTHALMOLOGY35646
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY33222
  •  

    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    下一頁    末頁  (頁
/1)
  [JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS] 的評論撰寫評論
作者: 南风壬午


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-11-29 09:08:37 評論於
How long does it take to accept submissions?
(0) 讚! | 南风壬午

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 17:44:40 評論於
I love traveling to new places and experiencing different cultures. It allows me to broaden my perspective and learn new things. Travelling also helps me unwind and relax
(0) 讚! | 维尔娜菲茨杰拉德

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 13:41:31 評論於
Research background, significance, development status, etc. The growth of the population and the rapid development of economy leads to the increasingly serious problem of environmental pollution. Environmental pollution not only affects human health but also endangers the sustainable development of society. In recent years, researchers have made great progress in the study of environmental protection and pollution control, but there are still many challenges to be faced.

Problematic issues that have not been solved or need urgent solutions, leading to the introduction of the researcher's motives and significance. With the acceleration of industrialization and urbanization, the emission of pollutants into the environment has been increasing, leading to more severe environmental pollution problems. It is urgent to find effective ways to control pollution and protect the environment.

Specific purpose of the study. The purpose of this study is to explore new methods and technologies for environmental protection and pollution control, aiming to provide practical solutions to environmental problems and promote sustainable development. Through in-depth research and analysis, the study aims to provide valuable insights and guidance for the development of environmental protection policies and measures
(0) 讚! | 维尔娜菲茨杰拉德

作者: 上清雨真


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-27 15:48:37 評論於
Is the introduction generally three paragraphs?
(0) 讚! | 上清雨真

作者: 魂魄彦露


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-26 14:09:20 評論於
What does the introduction three-part system refer to?
(0) 讚! | 魂魄彦露

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2013-10-14 18:37:15 評論於
This magazine is still very well received. We had an article that was rejected wherever we submitted it, but luckily it was accepted by this magazine
(0) 讚! | 凌霄高洁

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2013-04-21 22:36:33 評論於
Please translate the following paragraph into English and Japanese, and title each with ":" and ":"
(0) 讚! | 凌霄高洁

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2013-04-21 12:04:22 評論於
 (0) 讚! | 凌霄高洁  

作者: Daisy Electra


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2011-07-01 21:06:34 評論於
Review speed: 1.0 | Submission hit rate: 5.0 
Experience sharing: Keep up the good work in submitting, persist and you will eventually succeed!
(0) 讚! | Daisy Electra

首頁    上一頁    1    下一頁    末頁  (頁
/1)

開始撰寫 [JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*